Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fénichel, P.
Right arrow Articles by Pointis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fénichel, P.
Right arrow Articles by Pointis, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 8, 2020-2024, August 1999
© 1999 European Society of Human Reproduction and Embryology

Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia

P. Fénichel1,3, R. Rey2, S. Poggioli1, M. Donzeau1, D. Chevallier1 and G. Pointis1

1 Groupe de Recherche sur l'Interaction Gamétique CJF INSERM 95–04, Institut Fédératif de Recherche 50, Faculté de Médecine, 06107 Nice, and 2 Unité de Recherches sur l'Endocrinologie du Développement, INSERM U493, Ecole Normale Supérieure, Département de Biologie, 92120 Montrouge, France

Anti-Müllerian hormone (AMH) also known as Müllerian inhibiting substance or factor, is a Sertoli cell-secreted glycoprotein responsible in male embryos for Müllerian duct regression. However, its role in adults remains unknown. AMH seminal concentrations have been evaluated using an enzyme-linked immunoassay in three groups of young men: group 1, fertile donors (n = 18); group 2, obstructive azoospermia (n = 9) after vasectomy or associated with deferent duct agenesia; and group 3, non-obstructive azoospermia with spermatogenesis deficiency and normal karyotype (n = 23). AMH was present in seminal plasma of most fertile donors at concentrations ranging from undetectable (<3.5 pmol/l) up to 543 pmol/l (geometric mean: 153 pmol/l), higher than the serum level (range <3.5 up to 67 pmol/l, geometric mean: 10.7 pmol/l, n = 13). Seminal AMH concentrations were undetectable in all obstructive azoospermic patients, confirming its testicular origin. In non-obstructive azoospermia (group 3), seminal AMH concentration was lower (range <3.5–68.5 pmol/l, geometric mean: 17 pmol/l) than in fertile donors (P < 0.003) without correlation with plasma follicle stimulating hormone values. In group 3, comparison of seminal AMH concentration and the results of histological analysis of testicular biopsies revealed that undetectable AMH found in 14 cases was associated in 11 of them with lack of spermatozoa, while detectable concentrations of AMH (10–68.5 pmol/l) found in nine cases were associated in seven of them with persistent spermatogenesis. In the adult, AMH is secreted preferentially towards the seminiferous lumen. Although its relationship with spermatogenesis requires further investigation, our results suggest that seminal AMH may represent a non-invasive marker of persistent hypospermatogenesis in cases of non-obstructive azoospermia which may indicate the likely success of testicular spermatozoa recovery before intracytoplasmic sperm injection.

Key words: anti-Müllerian hormone/non-obstructive azoospermia/seminal marker/spermatogenesis/testicular sperm injection

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
A.A. Sinisi, D. Esposito, L. Maione, M.C. Quinto, D. Visconti, A. De Bellis, A. Bellastella, G. Conzo, and G. Bellastella
Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism
Hum. Reprod., May 1, 2008; 23(5): 1029 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Koscinski, C. Wittemer, J.M. Rigot, M. De Almeida, E. Hermant, and A. Defossez
Seminal haploid cell detection by flow cytometry in non-obstructive azoospermia: a good predictive parameter for testicular sperm extraction
Hum. Reprod., July 1, 2005; 20(7): 1915 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
O. Blagosklonova, C. Joanne, C. Roux, H. Bittard, F. Fellmann, and J.L. Bresson
Absence of anti-Mullerian hormone (AMH) and M2A immunoreactivities in Sertoli cell-only syndrome and maturation arrest with and without AZF microdeletions
Hum. Reprod., August 1, 2002; 17(8): 2062 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Sousa, N. Cremades, J. Silva, C. Oliveira, L. Ferraz, J.T. da Silva, P. Viana, and A. Barros
Predictive value of testicular histology in secretory azoospermic subgroups and clinical outcome after microinjection of fresh and frozen-thawed sperm and spermatids
Hum. Reprod., July 1, 2002; 17(7): 1800 - 1810.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Fujisawa, T. Yamasaki, H. Okada, and S. Kamidono
The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis
Hum. Reprod., April 1, 2002; 17(4): 968 - 970.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. L. Segev, Y. Hoshiya, M. Hoshiya, T. T. Tran, J. L. Carey, A. E. Stephen, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo
PNAS, January 1, 2002; (2002) 221599298.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Starita-Geribaldi, S. Poggioli, M. Zucchini, J. Garin, D. Chevallier, P. Fenichel, and G. Pointis
Mapping of seminal plasma proteins by two-dimensional gel electrophoresis in men with normal and impaired spermatogenesis
Mol. Hum. Reprod., August 1, 2001; 7(8): 715 - 722.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Amer, T. A. Elnasser, S. E. Haggar, T. Mostafa, G. Abdel-Malak, and W. Zohdy
May-Grunwald-Giemsa stain for detection of spermatogenic cells in the ejaculate: a simple predictive parameter for successful testicular sperm retrieval
Hum. Reprod., July 1, 2001; 16(7): 1427 - 1432.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. L. Ballesca, J. Balasch, J. M Calafell, R. Alvarez, F. Fabregues, M J. M. de Osaba, C. Ascaso, and J. A. Vanrell
Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia
Hum. Reprod., August 1, 2000; 15(8): 1734 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. L. Segev, Y. Hoshiya, M. Hoshiya, T. T. Tran, J. L. Carey, A. E. Stephen, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo
PNAS, January 8, 2002; 99(1): 239 - 244.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.